<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2025-4-66-71</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1811</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Применение вспомогательных технологий в лечении пациентов с системной склеродермией: серия клинических случаев</article-title><trans-title-group xml:lang="en"><trans-title>Use of adjunctive technologies in the treatment of patients with systemic sclerosis: a case series</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-2859-1611</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смелянцева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smelyantseva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1172-1116</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Слепова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Slepova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8907-8370</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаева</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaeva</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Надежда Андреевна Николаева,</p><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>Nadezhda Andreevna Nikolaeva,</p><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><email xlink:type="simple">nadnikolya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3391-0193</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лишута</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Lishuta</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5169-0740</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пак</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pak</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3181-5272</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Меньшикова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Menshikova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3014-6129</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беленков</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belenkov</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119048, Москва, Трубецкая ул., 8, стр. 2</p></bio><bio xml:lang="en"><p>8, Trubetskaya Street, Build. 2, Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2025</year></pub-date><volume>19</volume><issue>4</issue><fpage>66</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смелянцева Е.А., Слепова О.А., Николаева Н.А., Лишута А.С., Пак Ю.В., Меньшикова И.В., Беленков Ю.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Смелянцева Е.А., Слепова О.А., Николаева Н.А., Лишута А.С., Пак Ю.В., Меньшикова И.В., Беленков Ю.Н.</copyright-holder><copyright-holder xml:lang="en">Smelyantseva E.A., Slepova O.A., Nikolaeva N.A., Lishuta A.S., Pak Y.V., Menshikova I.V., Belenkov Y.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1811">https://mrj.ima-press.net/mrj/article/view/1811</self-uri><abstract><p>Пациенты с системной склеродермией (ССД) являются гетерогенной и сложной в лечении группой. Прогрессирование заболевания зачастую может быть ассоциировано не только со снижением качества жизни, но и с развитием тяжелых органных поражений. Возможности лечения пациентов с ССД на сегодняшний день ограниченны, несмотря на значительные успехи, связанные с применением генно-инженерных биологических препаратов.</p><p>Использование методов вспомогательного лечения, оказывающих влияние на периферическое сосудистое русло, потенциально могло бы улучшить результаты терапии этой группы больных. В частности, усиленная наружная контрпульсация (УНКП) хорошо зарекомендовала себя при рефрактерной стенокардии. Благодаря положительному влиянию на функцию эндотелия этот метод мог бы использоваться не только в кардиологии, но и при системных заболеваниях соединительной ткани, в основе патогенеза которых лежат прогрессирующее ремоделирование микроциркуляторного русла и гипоксия тканей.</p><p>В статье представлена серия клинических случаев, демонстрирующих первый опыт применения УНКП у 3 пациенток с ССД в дополнение к подобранной оптимальной медикаментозной терапии.</p></abstract><trans-abstract xml:lang="en"><p>Patients with systemic sclerosis (SSc) represent a heterogeneous and therapeutically challenging group. Disease progression is often associated not only with reduced quality of life but also with severe organ involvement. Despite advances in the use of biologic agents, treatment options for SSc remain limited.</p><p>Adjunctive treatment methods that target the peripheral vascular system may offer therapeutic benefit for this population. Enhanced external counterpulsation (EECP), which has shown efficacy in refractory angina, could also hold potential in systemic connective tissue diseases. Its positive impact on endothelial function suggests utility beyond cardiology in diseases where progressive microvascular remodeling and tissue hypoxia play key pathogenic roles.</p><p>This article presents a case series describing the initial experience of EECP use in 3 female patients with SSc as an adjunct to optimized pharmacological therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>системная склеродермия</kwd><kwd>лечение</kwd><kwd>усиленная наружная контрпульсация</kwd><kwd>капилляроскопия</kwd><kwd>микроциркуляция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>systemic sclerosis</kwd><kwd>treatment</kwd><kwd>enhanced external counterpulsation</kwd><kwd>capillaroscopy</kwd><kwd>microcirculation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мамиева ЗА, Лишута АС, Беленков ЮН. и др. Возможности применения усиленной наружной контрпульсации в клинической практике. Рациональная Фармакотерапия в Кардиологии. 2017;13(2):238-247.</mixed-citation><mixed-citation xml:lang="en">Mamieva ZA, Lishuta AS, Belenkov YuN, et al. Possibilities of Enhanced External Counterpulsation Using in Clinical Practice. Ratsional'naya Farmakoterapiya v Kardiologii. 2017;13(2):238-247. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hui JCK, Lawson WE, Barsness GW. EECP in the treatment of endothelial dysfunction: preventing progression of cardiovascular disease. Journal of Geriatric Cardiology. 2010;7(2):79-87.</mixed-citation><mixed-citation xml:lang="en">Hui JCK, Lawson WE, Barsness GW. EECP in the treatment of endothelial dysfunction: preventing progression of cardiovascular disease. Journal of Geriatric Cardiology. 2010;7(2):79-87.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бокерия ЛА, Бокерия ОЛ, Глушко ЛА и др. Новые возможности, перспективы и расширение клинических показаний к применению метода усиленной наружной контрпульсации. Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2021;22(2):119-29.</mixed-citation><mixed-citation xml:lang="en">Bockeria LA, Bockeria OL, Glushko LA, et al. New opportunities, prospects and the expansion of clinical indications for the use of enhanced external counterpulsation. Byulleten' NTsSSKh im. A.N. Bakuleva RAMN. 2021; 22(2):119-29. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Xu L, Cui M, Zhao W. The Effect of EECP on Ischemic Heart Failure: a Systematic Review. Curr Cardiol Rep. 2023 Oct;25(10):1291- 1298. doi: 10.1007/s11886-023-01943-1. Epub 2023 Aug 29.</mixed-citation><mixed-citation xml:lang="en">Xu L, Cui M, Zhao W. The Effect of EECP on Ischemic Heart Failure: a Systematic Review. Curr Cardiol Rep. 2023 Oct;25(10):1291- 1298. doi: 10.1007/s11886-023-01943-1. Epub 2023 Aug 29.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Akhtar M, Wu G, Du Z, et al. Effect of External Counterpulsation on Plasma Nitric Oxide and Endothelin-1 Levels. Am J Cardiol. 2006 Jul 1;98(1):28-30. doi: 10.1016/j.amjcard. 2006.01.053. Epub 2006 May 3.</mixed-citation><mixed-citation xml:lang="en">Akhtar M, Wu G, Du Z, et al. Effect of External Counterpulsation on Plasma Nitric Oxide and Endothelin-1 Levels. Am J Cardiol. 2006 Jul 1;98(1):28-30. doi: 10.1016/j.amjcard. 2006.01.053. Epub 2006 May 3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">https://www.consultant.ru/document/cons_doc_LAW_384782/</mixed-citation><mixed-citation xml:lang="en">https://www.consultant.ru/document/cons_doc_LAW_384782/</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999 Jun;33(7):1833-40. doi: 10.1016/s0735-1097(99)00140-0.</mixed-citation><mixed-citation xml:lang="en">Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999 Jun;33(7):1833-40. doi: 10.1016/s0735-1097(99)00140-0.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Subramanian R, Nayar S, Meyyappan C, et al. Effect of Enhanced External Counter Pulsation Treatment on Aortic Blood Pressure, Arterial Stiffness and Ejection Fraction in Patients with Coronary Artery Disease. J Clin Diagn Res. 2016 Oct;10(10):OC30- OC34. doi: 10.7860/JCDR/2016/23122.8743. Epub 2016 Oct 1.</mixed-citation><mixed-citation xml:lang="en">Subramanian R, Nayar S, Meyyappan C, et al. Effect of Enhanced External Counter Pulsation Treatment on Aortic Blood Pressure, Arterial Stiffness and Ejection Fraction in Patients with Coronary Artery Disease. J Clin Diagn Res. 2016 Oct;10(10):OC30- OC34. doi: 10.7860/JCDR/2016/23122.8743. Epub 2016 Oct 1.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sahebjami F, Madani FR, Komasi S, et al. Refractory angina frequencies during 7 weeks treatment by enhanced external counterpulsation in coronary artery disease patients with and without diabetes. Ann Card Anaesth. 2019 Jul-Sep;22(3):278-282. doi: 10.4103/aca.ACA_86_18.</mixed-citation><mixed-citation xml:lang="en">Sahebjami F, Madani FR, Komasi S, et al. Refractory angina frequencies during 7 weeks treatment by enhanced external counterpulsation in coronary artery disease patients with and without diabetes. Ann Card Anaesth. 2019 Jul-Sep;22(3):278-282. doi: 10.4103/aca.ACA_86_18.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao M, Huang Y, Li L, et al. Enhanced External Counterpulsation Efficacy on Exercise Endurance in COPD Patients and Healthy Subjects: A Pilot Randomized Clinical Trial. Int J Chron Obstruct Pulmon Dis. 2020 Jan 7:15:25-31. doi: 10.2147/COPD.S225566. eCollection 2020.</mixed-citation><mixed-citation xml:lang="en">Zhao M, Huang Y, Li L, et al. Enhanced External Counterpulsation Efficacy on Exercise Endurance in COPD Patients and Healthy Subjects: A Pilot Randomized Clinical Trial. Int J Chron Obstruct Pulmon Dis. 2020 Jan 7:15:25-31. doi: 10.2147/COPD.S225566. eCollection 2020.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Шилкина НП, Юнонин ИЕ, Столярова СА, Виноградов АА. Эндотелиальная дисфункция и нейрогуморальная регуляция артериального давления у больных системной склеродермией. Научно-практическая ревматология. 2019;57(4):445-451.</mixed-citation><mixed-citation xml:lang="en">Shilkina NP, Yunonin IE, Stolyarova SA, Vinogradov AA. Endothelial dysfunction and neurohumoral regulation of blood pressure in patients with systemic scleroderma. Nauchno-prakticheskaya revmatologiya. 2019;57(4): 445-451. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yin Q, Jiang H, Zhang Z, et al. Influence of enhanced external counterpulsation on endothelial function: a meta-analysis of randomized controlled trials. Scand Cardiovasc J. 2023 Dec;57(1):2273223. doi: 10.1080/14017431.2023.2273223. Epub 2023 Oct 24.</mixed-citation><mixed-citation xml:lang="en">Yin Q, Jiang H, Zhang Z, et al. Influence of enhanced external counterpulsation on endothelial function: a meta-analysis of randomized controlled trials. Scand Cardiovasc J. 2023 Dec;57(1):2273223. doi: 10.1080/14017431.2023.2273223. Epub 2023 Oct 24.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Romanowska-Prуchnicka K, Dziewit M, Lesiak A, et al. Scleroderma and sclerodermalike syndromes. Front Immunol. 2024 Jun 3:15:1351675. doi: 10.3389/fimmu.2024.1351675. eCollection 2024.</mixed-citation><mixed-citation xml:lang="en">Romanowska-Prуchnicka K, Dziewit M, Lesiak A, et al. Scleroderma and sclerodermalike syndromes. Front Immunol. 2024 Jun 3:15:1351675. doi: 10.3389/fimmu.2024.1351675. eCollection 2024.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Q, Hao J, Jiang W, Tan Q. Enhanced external counterpulsation increases coronary flow reserve in coronary microvascular disease. Saudi Med J. 2023 Dec;44(12): 1277-1282. doi: 10.15537/smj.2023.44.12.20230427.</mixed-citation><mixed-citation xml:lang="en">Wang Q, Hao J, Jiang W, Tan Q. Enhanced external counterpulsation increases coronary flow reserve in coronary microvascular disease. Saudi Med J. 2023 Dec;44(12): 1277-1282. doi: 10.15537/smj.2023.44.12.20230427.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Qin X, Deng Y, Wu D, et al. Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion? A Systematic Review &amp; Meta-Analysis. PLoS One. 2016 Apr 5;11(4):e0151822. doi: 10.1371/journal.pone.0151822. eCollection 2016.</mixed-citation><mixed-citation xml:lang="en">Qin X, Deng Y, Wu D, et al. Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion? A Systematic Review &amp; Meta-Analysis. PLoS One. 2016 Apr 5;11(4):e0151822. doi: 10.1371/journal.pone.0151822. eCollection 2016.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Singh V, Kumari G, Chhajer B, et al. Enhanced external counterpulsation effectiveness on clinical parameters in diabetic and non-diabetic coronary heart disease patients. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(7):151-157. doi: 10.22159/ajpcr.2018.v11i7.25219.</mixed-citation><mixed-citation xml:lang="en">Singh V, Kumari G, Chhajer B, et al. Enhanced external counterpulsation effectiveness on clinical parameters in diabetic and non-diabetic coronary heart disease patients. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(7):151-157. doi: 10.22159/ajpcr.2018.v11i7.25219.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nagendra L, Dutta D, Sharma M, Bg H. Impact of Enhanced External Counter-pulsation Therapy on Glycaemic Control in People With Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. TouchREV Endocrinol. 2023 Nov;19(2):9-15. doi: 10.17925/EE.2023.19.2.8. Epub 2023 Oct 2.</mixed-citation><mixed-citation xml:lang="en">Nagendra L, Dutta D, Sharma M, Bg H. Impact of Enhanced External Counter-pulsation Therapy on Glycaemic Control in People With Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. TouchREV Endocrinol. 2023 Nov;19(2):9-15. doi: 10.17925/EE.2023.19.2.8. Epub 2023 Oct 2.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Buschmann EE, Brix M, Li L, et al. Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease. Vasa. 2016;45(4): 317-24. doi: 10.1024/0301-1526/a000544.</mixed-citation><mixed-citation xml:lang="en">Buschmann EE, Brix M, Li L, et al. Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease. Vasa. 2016;45(4): 317-24. doi: 10.1024/0301-1526/a000544.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Zhang Y, Wang Y, et al. Effects of Enhanced External Counterpulsation With Different Sequential Levels on Lower Extremity Hemodynamics. Front Cardiovasc Med. 2021 Dec 24:8:795697. doi: 10.3389/fcvm.2021.795697. eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Zhang Y, Wang Y, et al. Effects of Enhanced External Counterpulsation With Different Sequential Levels on Lower Extremity Hemodynamics. Front Cardiovasc Med. 2021 Dec 24:8:795697. doi: 10.3389/fcvm.2021.795697. eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Munteanu A, Kundnani NR, Caraba A. Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients. Eur Rev Med Pharmacol Sci. 2024 Feb;28(4): 1314-1326. doi: 10.26355/eurrev_202402_35453.</mixed-citation><mixed-citation xml:lang="en">Munteanu A, Kundnani NR, Caraba A. Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients. Eur Rev Med Pharmacol Sci. 2024 Feb;28(4): 1314-1326. doi: 10.26355/eurrev_202402_35453.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Buschmann EE, Hillmeister P, Bondke Persson A, et al. Short-term external counterpulsation augments cerebral blood flow and tissue oxygenation in chronic cerebrovascular occlusive disease. Eur J Neurol. 2018 Nov; 25(11):1326-1332. doi: 10.1111/ene.13725.</mixed-citation><mixed-citation xml:lang="en">Buschmann EE, Hillmeister P, Bondke Persson A, et al. Short-term external counterpulsation augments cerebral blood flow and tissue oxygenation in chronic cerebrovascular occlusive disease. Eur J Neurol. 2018 Nov; 25(11):1326-1332. doi: 10.1111/ene.13725.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
